Menu

Dogs in Southern China Host Several Strains of Flu

They may be a prospective source for an influenza pandemic, researchers warn.  

Jun 6, 2018
Sukanya Charuchandra

ISTOCK, CHALABALANew research published in mBio yesterday (June 5) proposes that dogs may be a potential reservoir for an influenza pandemic. Researchers found three new hybrid canine strains (with porcine and avian origins) in dogs from Southern China.

“The more diversity of viruses there is in an animal reservoir, the higher the chances that it will lead to a version of the virus that is able to jump,” Adolfo García-Sastre, the director of the Global Health and Emerging Pathogens Institute of the Icahn School of Medicine at Mount Sinai and a coauthor on the paper, tells Science News.

See “First Human Case of H7N4 Bird Flu Confirmed

García-Sastre and his colleagues collected 16 viral genome samples from pet dogs diagnosed with respiratory infections in Southern China from 2013-15. Researchers identified three variants usually found in swine and the three new hybrids that formed by mixing with a canine strain. These newly found variants are H1N1, but unlike the H1N1 swine flu, these have hopped from birds to pigs to dogs, ultimately creating new versions.

“What this study provides is evidence that dogs can be naturally infected with multiple strains of viruses, most notably viruses from pigs, which are a known reservoir of influenza viruses that can infect us,” Jonathan Ball, a virologist at the University of Nottingham in the U.K., who was not involved with the research, tells The Independent. According to Ball, the source of the next epidemic is anybody’s guess, but a canine one can’t be ruled out.

See “Not Swine Flu

According to a statement, the team plans to determine if humans are immune to these new variants. In the meantime, García-Sastre suggests vaccinating dogs and monitoring the situation to ensure the flu does not crossover into humans, according to The Telegraph.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.